Loading company…
Tel Aviv-based Scopio Labs Ltd. makes digital cell morphology imaging platforms that help hematology labs analyze blood samples.
Founded in 2015 and headquartered in Tel Aviv, Israel, Scopio Labs Ltd. sells the Scopio X100 and X100HT imaging platforms, which use computational photography and AI to image cell samples in hematology labs. In July 2025 the company raised USD 10 million in Series D funding led by new investor Viola Goup. CEO Itai Hayut leads the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in